Yarlagadda S. Babu

2011

In 2011, Yarlagadda S. Babu earned a total compensation of $621.6K as Senior Vice President of Drug Discovery at BioCryst Pharmaceuticals, which was about the same as previous year.

Compensation breakdown

Non-Equity Incentive Plan$110,028
Option Awards$138,500
Salary$323,452
Stock Awards$37,350
Other$12,250
Total$621,580

Babu received $323.5K in salary, accounting for 52% of the total pay in 2011.

Babu also received $110K in non-equity incentive plan, $138.5K in option awards, $37.4K in stock awards and $12.3K in other compensation.

Rankings

In 2011, Yarlagadda S. Babu's compensation ranked 7,364th out of 10,747 executives tracked by ExecPay. In other words, Babu earned more than 31.5% of executives.

ClassificationRankingPercentile
All
7,364
out of 10,747
32nd
Division
Manufacturing
2,692
out of 3,960
32nd
Major group
Chemicals And Allied Products
661
out of 1,033
36th
Industry group
Drugs
460
out of 781
41st
Industry
Biological Products, Except Diagnostic Substances
78
out of 157
50th
Source: SEC filing on March 21, 2014.

Babu's colleagues

We found five more compensation records of executives who worked with Yarlagadda S. Babu at BioCryst Pharmaceuticals in 2011.

2011

Jon Stonehouse

BioCryst Pharmaceuticals

Chief Executive Officer

2011

Thomas Staab

BioCryst Pharmaceuticals

Chief Financial Officer

2011

William Sheridan

BioCryst Pharmaceuticals

Chief Medical Officer

2011

David McCullough

BioCryst Pharmaceuticals

Vice President, Strategic Planning, Commercialization and Corporate Development

2011

Stuart Grant

BioCryst Pharmaceuticals

Chief Financial Officer

News

You may also like